• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (COSTA RICA) INSPIRA SMOOTH SILICONE GEL FILLED BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (COSTA RICA) INSPIRA SMOOTH SILICONE GEL FILLED BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED Back to Search Results
Model Number SRLP-165
Medical Device Problem Code Patient-Device Incompatibility (2682)
Health Effect - Clinical Code Capsular Contracture (1761)
Date of Event 08/16/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.The event of capsular contracture is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.This is a known potential adverse event addressed in the product labeling.The reason for reoperation was/is capsular contracture baker grade iii/iv.
 
Event or Problem Description
Healthcare professional reported a left side capsular contracture baker grade iii/iv.Device remains implanted.
 
Event or Problem Description
Healthcare professional additionally reported "any creases" and patient "developed some type of acute viral illness which led to swelling and redness" of the left breast.
 
Additional Manufacturer Narrative
Additional, changed, and/or corrected data: b.5, b.6.
 
Additional Manufacturer Narrative
Additional, changed, and/or corrected data: b.5., d.7., g.1., g.3., h.6.
 
Event or Problem Description
Device has been explanted.
 
Additional Manufacturer Narrative
Additional, changed, and/or corrected data: b5, h6.Allergan did not submit this mdr within 30 days of becoming aware.Recent stimulated reporting related to 2011068-7/2/19-001-r has increased complaint and mdr volume.Allergan is implementing a plan to address the increased volumes.
 
Event or Problem Description
Device was discarded.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INSPIRA SMOOTH SILICONE GEL FILLED BREAST IMPLANT
Common Device Name
PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED
Manufacturer (Section D)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
CS 
MDR Report Key9101217
Report Number9617229-2019-14596
Device Sequence Number2656248
Product Code FTR
UDI-Device Identifier10888628006829
UDI-Public10888628006829
Combination Product (Y/N)N
Initial Reporter StateOR
PMA/510(K) Number
P020056
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Device Explanted Year2020
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 06/30/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date01/15/2024
Device Model NumberSRLP-165
Device Catalogue NumberSRLP-165
Device Lot Number3314054
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 08/21/2019
Supplement Date Received by Manufacturer08/26/2020
09/30/2020
03/15/2021
Initial Report FDA Received Date09/20/2019
Supplement Report FDA Received Date09/22/2020
10/30/2020
06/30/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age52 YR
-
-